CYP2C9 inactivates tolbutamide by 4methyl-hydroxylation

Stable Identifier
R-HSA-211988
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Tolbutamide is an oral hypoglycemic agent whose action is terminated by hydroxylation of the tolylsulfonyl methyl moiety. The reaction is catalyzed by CYP2C9.

Literature References
PubMed ID Title Journal Year
2025243 Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9

Veronese, ME, Mackenzie, PI, Doecke, CJ, McManus, ME, Miners, JO, Birkett, DJ

Biochem Biophys Res Commun 1991
Participants
Participant Of
hasEvent
Catalyst Activity
Catalyst Activity
Title
monooxygenase activity of Cytochrome P450 (CYP2C9 based) [endoplasmic reticulum membrane]
Physical Entity
Activity
Orthologous Events
Authored
Reviewed
Created